Meeting Agenda

Forum Agenda

July 23，09:00-12:10

Decree No. 818 and a New Era for the Development of Biomedicine Industry session

Stay tuned

Conference Planning
Jie Li，Senior Vice President, Regulatory Affairs, Aeira Health; Director, All-Chain Pharmaceutical Information Research Institute, Beijing Economic-Technological Development Area


moderator
Jinsheng Cheng，General Manager, Life Science Division, Tofflon

 

09:00-09:20   Interpreting Decree No. 818
Jianzhong Shen：Coordination Commissioner for the Implementation of Regulation 818 of the Biology Center, Second-Class Researcher (Former Deputy Director)


09:20-09:35   Decree No. 818 and the Boao Lecheng Pilot Zone
Jingle Liao：Deputy Director of the Hainan Boao Lecheng International Medical Tourism Pilot Zone Administration


09:35-09:50   Cell Therapy-Based Cancer Vaccines: Translational Practice Under Decree No. 818
Genhong Cheng：Fellow of the American Academy of Microbiology,Tenured Professor at UCLA,Distinguished Professor, Guangzhou Laboratory


09:50-10:05   New Biomedical Technologies in the Era of Decree No. 818
Biao Wu：Deputy Director, Changzhou West Taihu Institute of Advanced Cell Therapy Technology; Vice Chairman, China Medicinal Biotech Association


10:05-10:20   Building an End-to-End Support System for Decree No. 818: The West China Hospital Approach
Yuan Li：Deputy Director of the Department of Science and Technology and Director of the Research Platform Management Office, West China Hospital of Sichuan University


10:20-10:40  Tea break

 

10:40-10:55   Managing Somatic Cell Clinical Research Under Decree No. 818: The SYSUCC Experience and Practices
Tong Xiang，Associate Research Fellow, Experimental Research Department, Sun Yat-sen University Cancer Center


10:55-11:10   The Role of Ethics in Reviewing New Biomedical Technologies Under Decree No. 818
Jie Li:Director, Ethics Committee, Peking University Cancer Hospital


11:10-11:25   A Brief Analysis of CGT Product R&D Pathway Strategies and Prospects Under the 818/828 Policies
Zhihong Wan:Chief Scientist & New Drug Evaluation Expert, Boji Medical


11:25-12:10   Roundtable: Operationalizing Translational Biomedical Technologies Under the 818 Policy
Jie Li:Senior Vice President, Regulatory Affairs, Aeira Health; Director, All-Chain Pharmaceutical Information Research Institute, Beijing Economic-Technological Development Area
Guodong Jia:Distinguished Research Fellow, Nanhu Laboratory
Hongxin Deng:Professor, National Key Laboratory of Biotherapy, West China Hospital, Sichuan University
Xueli Geng:Executive General Manager, SDIC Venture Capital
Jinsheng Cheng:General Manager, Life Science Division, Tofflon
Mingyu Liu :Head of R&D and TIL Program Leader, Biosyngen

Follow or Contact Us

Follow the TONACEA Official WeChat Account and scan the QR code to register. Stay updated with the latest conference news.

Official Account QR Code

Public Account QR Code

Registration QR Code

Registration QR Code

Conference Service Hotline

+86 010 8363 4290

© 2026 TONACEA (Shanghai) Technology Development Co., Ltd. All rights reserved. All rights reserved.

Powered by：CEglobal

Image Name
Image Name
Image Name
Image Name
Image Name